Scisco Genetics — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Founded in 2017, Scisco Genetics operates in the competitive DTC genetic testing market, offering health and ancestry reports directly to consumers. The company leverages genotyping technology to analyze customer DNA samples, providing insights into genetic predispositions for various traits and wellness-related conditions. Its business model relies on kit sales and potential subscription services for updated reports, targeting health-conscious individuals seeking personalized data. As a private company, it faces significant competition from larger, well-established players and must navigate evolving regulatory and data privacy landscapes.

Genetics & GenomicsDiagnostics

Technology Platform

DNA genotyping microarray technology for analyzing SNPs related to ancestry, traits, and wellness predispositions, with digital reporting via an online portal.

Opportunities

The growing consumer interest in personalized health and preventive wellness creates a large addressable market.

Opportunities exist in developing subscription-based recurring revenue models and forming partnerships with wellness, fitness, or telehealth companies to integrate genetic insights into broader health platforms.

Risk Factors

Intense competition from larger, well-capitalized DTC genetics leaders poses a major threat to market share and customer acquisition costs.

Evolving regulatory scrutiny on health-related genetic claims and the constant risk of data privacy breaches present significant operational and reputational challenges.

Competitive Landscape

Scisco Genetics operates in a highly competitive market dominated by 23andMe and Ancestry.com, which have superior brand recognition, database size, and resources. It also competes with other DTC players like MyHeritage and newer wellness-focused entrants, as well as clinical testing companies expanding into consumer channels.

More companies in Diagnostics & Precision Medicine →More companies in United States →